Profil

Fanfone Déborah


Main Research Fields
Immunology & infectious disease
Oncology
Radiology, nuclear medicine & imaging
Zoology
Biotechnology
Main Keywords
peptides; galectin-1; molecular imaging; phage display; thyroid cancer;
Main Unit & Research Centers
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale
CISMA - Centre Interdisciplinaire de Spectrométrie de Masse
Main Co-authors
Vander Elst, Luce 
Saussez, Sven 
Burtea, Carmen 
Muller, Robert 
Laurent, Sophie 

Publications (total 21)

The most downloaded
3 downloads
Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (22 May 2015). Galectin-1, a potential molecular imaging biomarker of well-differentiated thyroid cancers. Poster session presented at Première Journée d'Etudes UMHAP, Mons, Belgium. https://hdl.handle.net/20.500.12907/25232
The most cited
11 citations (SCOPUS)
Burtea, C., Laurent, S., Sanli, T., Fanfone, D., Devalckeneer, A., Sauvage, S., Beckers, M.-C., Rorive, S., Salmon, I., Vander Elst, L., Lauwerys, B. R., & Muller, R. (10 November 2016). Screening for peptides targeted ti IL-7Ralpha for molecular imaging of rheumatoid arthritis synovium. Arthritis Research and Therapy, 18 (230). doi:10.1186/s13075-016-1133-8 https://hdl.handle.net/20.500.12907/25545

Fanfone, D., Stanicki, D., Nonclercq, D., Port, M., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (14 March 2020). Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes. Biology, 9 (53), 1-25. doi:10.3390/biology9030053
Peer reviewed

Fanfone, D., Despretz, N., Stanicki, D., Rubio Magnieto, J., Fossepre, M., Surin, M., Rorive, S., Salmon, I., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (2017). Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1. Medical Oncology.
Peer Reviewed verified by ORBi

Burtea, C., Laurent, S., Muller, R., Stanicki, D., Fanfone, D., & Saussez, S. (26 September 2017). Galectin-1 binding peptides and use thereof for diagnostic and therapeutic purpose.

Fanfone, D., Paternoster, Q., Stanicki, D., Fossepre, M., Surin, M., Rorive, S., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (16 March 2017). Imaging of papillary thyroid cancer using peptide vectorized iron oxide nanoparticles targeted to galectin-1. Paper presented at 3rd Belgium Molecular Imaging Congress, Bruxelles, Belgium.

Fanfone, D., Stanicki, D., Fossepre, M., Surin, M., Rorive, S., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (07 March 2017). Development of peptide vectorized contrast agents targeting galectin-1 in the context of imaging diagnosis of papillary thyroid cancer. Poster session presented at Mardi des Chercheurs (MdC2017), Mons, Belgium.

Fanfone, D., Stanicki, D., Fossepre, M., Surin, M., Rorive, S., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (08 December 2016). Papillary thyroid cancer diagnostic by galectin-1 targeting using peptide vectorized contrast agent for MRI. Paper presented at Séminaire des chercheurs Télévie 2017, Woluwé, Belgium.

Andre, S., Ansciaux, E., Larbanoix, L., Fanfone, D., Nonclercq, D., Vander Elst, L., Laurent, S., Muller, R., & Burtea, C. (29 November 2016). Targeting amyloid plaques for the early diagnosis of Alzheimer's disease: validation of a vectorized superparamagnetic contrast agent able to cross the blood-brain barrier. Poster session presented at BMIC 'Imaging in Drug Discovery and development', Janssen Pharmaceutica, Beerse, Belgium.

Burtea, C., Laurent, S., Sanli, T., Fanfone, D., Devalckeneer, A., Sauvage, S., Beckers, M.-C., Rorive, S., Salmon, I., Vander Elst, L., Lauwerys, B. R., & Muller, R. (10 November 2016). Screening for peptides targeted ti IL-7Ralpha for molecular imaging of rheumatoid arthritis synovium. Arthritis Research and Therapy, 18 (230). doi:10.1186/s13075-016-1133-8
Peer Reviewed verified by ORBi

Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Rorive, S., Vander Elst, L., Saussez, S., & Burtea, C. (03 September 2016). Study of novel galectin-1 targeted peptides in the context of a new and non-invasive papillary thyroid cancer diagnosis and evaluation of their potential inhibitor effect. Poster session presented at 39th annual meeting of the european thyroid association, Copenhague, Denmark.

Fanfone, D., Stanicki, D., Laurent, S., Rorive, S., Saussez, S., Vander Elst, L., Muller, R., & Burtea, C. (18 May 2016). Approche diagnostique non invasive du cancer thyroïdien à l'aide de peptides ciblant la galectine-1 à potentiel anti-cancéreux. Poster session presented at 9ème édition de la Matinée des Chercheurs 2016 (MdC2016), Valenciennes, France.

Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Rorive, S., Vander Elst, L., Saussez, S., & Burtea, C. (17 February 2016). Effects of novel galectin-1-targeted peptides on human cells in the context of a new and non-invasive thyroid cancer diagnosis. Poster session presented at Belgian Peptide Group Meeting, Bruxelles, Belgium.

Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (11 December 2015). Galectin-1, a potential molecular imaging biomarker of well-differentiated thyroid cancers. Poster session presented at Bioforum-bioliege, Liège, Belgium.

Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Rorive, S., Vander Elst, L., Saussez, S., & Burtea, C. (03 December 2015). Development of a galectin-1 targeted contrast agent for the MRI diagnosis of papillary thyroid cancer. Poster session presented at Televie's researchers seminar : towards new therapies for cancer patients, Gembloux, Belgium.

Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (03 October 2015). Development of a new diagnosis approach by MRI of papillary thyroid cancer using a vectorized contrast agent directed against galectin-1. Poster session presented at ESMRMB 2015 32th annual scientific meeting, Edimbourg, United Kingdom.

Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (22 May 2015). Galectin-1, a potential molecular imaging biomarker of well-differentiated thyroid cancers. Poster session presented at Première Journée d'Etudes UMHAP, Mons, Belgium.

Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (22 April 2015). Well-differentiated thyroid cancer diagnostic imaging: development of a non-invasive method by peptidic targeting of galectin-1. Paper presented at Belgium Molecular Imaging Community Congress, Bruxelles, Belgium.

Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (10 March 2015). Specific strategy of thyroïd cancer diagnosis by galectin-1 targeting. Poster session presented at 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.

Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (31 January 2015). Toward the development of a galectin-1 targeted imaging probe as a useful tool for the thyroid cancer diagnosis. Poster session presented at ABEC-BVSK Annual meeting (BACR), UCL Woluwé, Belgium.

Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (16 January 2015). Thyroid cancer imaging :peptidic targeting of galectin-1 as a diagnostic tool. Poster session presented at 7th annual meeting ISMRM Benelux, Ghent, Belgium.

Fanfone, D., Despretz, N., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (16 January 2015). Thyroid cancer imaging :peptidic targeting of galectin-1 as a diagnostic tool. Poster session presented at 7th annual meeting ISMRM Benelux, Ghent, Belgium.

Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (30 November 2014). Peptidic targeting of galectin-1 as a useful tool in the thyroid cancer diagnosis. Paper presented at EDT-Cancérologie expérimentale:annual mini symposium 'From clinic to lab and vice versa', Liège, Belgium.

Contact ORBi